RVL Pharmaceuticals plc
RVLPQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -97.33% | -70.24% | 7.11% | 19.11% | 31.71% |
| Total Depreciation and Amortization | 3.30% | 4.49% | -6.54% | -38.31% | -97.68% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -26.94% | 210.26% |
| Total Other Non-Cash Items | 416.15% | -7.58% | 588.95% | -40.49% | -142.60% |
| Change in Net Operating Assets | -114.03% | 106.35% | 33.64% | 357.24% | 64,833.33% |
| Cash from Operations | -704.31% | 56.18% | 32.64% | 36.61% | 168.31% |
| Capital Expenditure | -- | -4,729.63% | -460.00% | 90.35% | 100.00% |
| Sale of Property, Plant, and Equipment | 52.63% | 113.51% | 956.00% | 1,606.67% | 159.09% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,782.46% | -12,350.00% | -129.33% | -99.79% | 105.97% |
| Total Debt Issued | -- | -- | -96.88% | -- | -- |
| Total Debt Repaid | 51.16% | -442.83% | 99.05% | 99.67% | 82.92% |
| Issuance of Common Stock | -- | -22.69% | -- | 18,012.21% | -100.00% |
| Repurchase of Common Stock | 77.03% | -26.32% | -87.50% | 98.13% | 70.28% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 53.11% | -480.65% | -97.53% | 122.68% | 82.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,357.56% | 15.60% | -147.39% | 135.37% | 111.36% |